Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/s41388-025-03514-w | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Corrigendum] Cerebral ischemic post‑conditioning induces autophagy inhibition and a HMGB1 secretion attenuation feedback loop to protect against ischemia reperfusion injury in an oxygen glucose deprivation cellular model.
Mol Med Rep
October 2025
Department of Neurology, Shengjing Hospital, Affiliated Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.
Subsequently to the publication of the above paper, the authors drew to the Editor's attention that matching HMGB1 bands featured in Figs. 4 and 5 had inadvertently been included in these figures twice; moreover, the GAPDH western blot controls featured in Fig. 3 had also been selected incorrectly.
View Article and Find Full Text PDFCorrection: HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium.
Oncogene
September 2025
Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Correction: Berberine ameliorates subarachnoid hemorrhage injury via induction of Sirtuin 1 and inhibiting HMGB1/Nf-κB pathway.
Front Pharmacol
July 2025
Department of Neurosurgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
[This corrects the article DOI: 10.3389/fphar.2020.
View Article and Find Full Text PDFCorrection: HMGB1 release and redox regulates autophagy and apoptosis in cancer cells.
Oncogene
August 2025
The DAMP Laboratory, Department of Surgery, Hillman Cancer Center, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA.
Correction to "CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma".
World J Gastroenterol
May 2025
Department of Radiotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300000, China.
[This corrects the article on p. 2308 in vol. 23, PMID: 28428710.
View Article and Find Full Text PDF